当前位置:APASL-en-亚太肝脏研究协会年会 >> 正文
[APASL2014]HBIG Is Being Phased Out!——Interview with Prof.James Fung
—— 作者:J.Fung 时间:2014-03-12
阅读数:
132
简介:Currently there is no single defining prophylactic protocol for antiviral therapy after liver transplantation because of all of the new antiviral therapies that have become available in the last four or five years. Different centers have adopted different regimens. If you go back the best part of a decade, I think the most widely accepted protocol has been the combination of HBIG and lamivudine.
请登录后查看详细内容
标签:
专家访谈
专家访谈
乙肝
发表评论
全部评论